Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients

  • Author: José R. Arribas, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 10/12/18 (What's New)

Summary

  • Potential reasons for considering a modification to the antiretroviral regimen of a virologically suppressed patient include tolerability and toxicity (Table 1)[Elzi 2010] and/or to preserve treatment options, avoid or manage drug–drug or drug–food interactions, or decrease cost (Table 2)
  • The DHHS antiretroviral therapy guidelines panel outlines specific criteria for patients on suppressive antiretroviral therapy to be considered for treatment modification (Management Guidelines)[DHHS ART]
    • The panel recently instituted evidence-based categorization of switch strategies for virologically suppressed patients into strategies with good supporting evidence, strategies with some evidence, or strategies not recommended (Table 3)

Action required